Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: A nationwide survey in Taiwan

Medicine and Dentistry

• Adult 100%
• Patient 100%
• Drug Therapy 100%
• Attention Deficit Disorder 100%
• Adult Attention Deficit Hyperactivity Disorder 100%
• Methylphenidate 80%
• Diagnosis 60%
• Therapeutic Procedure 40%
• Health 20%
• Incidence 20%
• Age 20%
• Male 20%
• Female 20%
• Prevalence 20%
• Awareness 20%
• Treatment Duration 20%
• Clinical Intervention 20%
• Functional Disease 20%
• Ethnic Groups 20%
• Patient with Attention Deficit Hyperactivity Disorder 20%

Psychology

• Attention Deficit 100%
• Methylphenidate 80%
• Treatment 60%
• Groups 20%
• Health 20%
• Functional Impairment 20%
• Pharmacological Treatment 20%

Neuroscience

• Attention Deficit Hyperactivity Disorder 100%
• Methylphenidate 66%
• Atomoxetine 33%